These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8926574)

  • 21. Cloning, expression and characterization of rhesus macaque types 1 and 2 5alpha-reductase: evidence for mechanism-based inhibition by finasteride.
    Ellsworth KP; Azzolina BA; Cimis G; Bull HG; Harris GS
    J Steroid Biochem Mol Biol; 1998 Sep; 66(5-6):271-9. PubMed ID: 9749833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition.
    Azzolina B; Ellsworth K; Andersson S; Geissler W; Bull HG; Harris GS
    J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):55-64. PubMed ID: 9328210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase by 6-azaandrost-4-en-3-ones: optimization of the C17 substituent.
    Frye SV; Haffner CD; Maloney PR; Hiner RN; Dorsey GF; Noe RA; Unwalla RJ; Batchelor KW; Bramson HN; Stuart JD
    J Med Chem; 1995 Jul; 38(14):2621-7. PubMed ID: 7629802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
    Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
    Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
    Schwartz JI; Van Hecken A; De Schepper PJ; De Lepeleire I; Lasseter KC; Shamblen EC; Winchell GA; Constanzer ML; Chavez CM; Wang DZ; Ebel DL; Justice SJ; Gertz BJ
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2942-7. PubMed ID: 8768856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finasteride is the main inhibitor of 5alpha-reductase activity in microdissected dermal papillae of human hair follicles.
    Hoffmann R; Happle R
    Arch Dermatol Res; 1999; 291(2-3):100-3. PubMed ID: 10195397
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo investigation in pigs of intestinal absorption, hepatobiliary disposition, and metabolism of the 5α-reductase inhibitor finasteride and the effects of coadministered ketoconazole.
    Lundahl A; Hedeland M; Bondesson U; Lennernäs H
    Drug Metab Dispos; 2011 May; 39(5):847-57. PubMed ID: 21317368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epididymis in an experimental model of DHT deficiency: immunolocalization of ERalpha and ERbeta in rat epididymal epithelial cells. In vivo and in vitro studies].
    Kolasa A
    Ann Acad Med Stetin; 2006; 52(2):13-21; discussion 21. PubMed ID: 17633123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors.
    Aggarwal S; Mahapatra MK; Kumar R; Bhardwaj TR; Hartmann RW; Haupenthal J; Kumar M
    Bioorg Med Chem; 2016 Feb; 24(4):779-88. PubMed ID: 26780831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma androsterone/epiandrosterone sulfates as markers of 5 alpha-reductase activity: effect of finasteride in normal men.
    Lewis JG; George PM; Elder PA
    Steroids; 1997; 62(8-9):632-5. PubMed ID: 9292937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Liquid Chromatography/Mass Spectrometry-Based Inhibition Assay for the Screening of Steroid 5-α Reductase in Human and Fish Cell Lines.
    Kim D; Cho H; Eggers R; Kim SK; Ryu CS; Kim YJ
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33567691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence study of finasteride. Determination in human plasma by high-pressure liquid chromatography coupled to tandem mass spectrometry.
    de Menezes FG; Ribeiro W; Ifa DR; de Moraes ME; de Moraes MO; De Nucci G
    Arzneimittelforschung; 2001 Feb; 51(2):145-50. PubMed ID: 11258044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel in vitro model to screen steroid 5 alpha-reductase inhibitors against benign prostatic hyperplasia.
    Sun ZY; Tu ZH
    Methods Find Exp Clin Pharmacol; 1998 May; 20(4):283-7. PubMed ID: 9658376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
    Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
    Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of finasteride on the ovulatory function of normal women.
    Wong IL; Morris RS; Lobo RA
    Fertil Steril; 2003 Jun; 79(6):1455-7. PubMed ID: 12798901
    [No Abstract]   [Full Text] [Related]  

  • 40. Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
    Kokate TG; Banks MK; Magee T; Yamaguchi S; Rogawski MA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):679-84. PubMed ID: 9918575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.